Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Generic Labeling: FDA Ponders Global Process Uniformity

This article was originally published in The Pink Sheet Daily

Executive Summary

Generic firms argue their data is not sufficient to recommend safety labeling changes, but FDA’s Dal Pan asks if they recommend changes in other countries, shouldn’t they be able to do the same in the US?

You may also be interested in...



US FDA Looks To Proactively Update Old Generic Drug Labels Under Pilot

Concept mentioned during Gottlieb’s 'star' turn at Davos may sound similar to now-withdrawn generic labeling rule, but actually appears based on a proposal from the Friends of Cancer Research to get current clinical guidelines reflected on labels.

US FDA Looks To Proactively Update Old Generic Drug Labels Under Pilot

Concept mentioned during Gottlieb’s 'star' turn at Davos may sound similar to now-withdrawn generic labeling rule, but actually appears based on a proposal from the Friends of Cancer Research to get current clinical guidelines reflected on labels.

Gottlieb Q&A: Sen. Murray Wants To Know About Generic Labeling Rule

US FDA Commissioner nominee offers master class in how to respond to congressional inquiries – and throws in some policy insight for good measure.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS078311

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel